Tag
NYSE: GSK
- Allarity Therapeutics announces stenoparib dosing patent into 2045
- Enanta Pharmaceuticals starts late-stage RSV trial with 2027 data due
- Arbutus Biopharma says FDA lifts AB‑101 clinical hold
- GSK wins FDA approval for Hibsago in chronic hepatitis B
- New Nova Scotia lung clinic aims to slash years-long waits for breathing tests
- GSK small-cell lung cancer drug gets nod from European Medicines Agency
- NetraMark demonstrates efficacy of AI to help with clinical trials
- GSK acquires late-stage Canadian biopharma company BELLUS Health for USD$2B